Effects of some motion sickness suppressants on static and dynamic tracking performance.
Two studies examined the influence of three established antimotion sickness drugs on tracking performance in static (stationary) and dynamic (angular acceleration) conditions and on visual fixation ability during motion. In Study I, 40 young men were randomly assigned in equal numbers to either a control (lactose placebo), dimenhydrinate (50 mg), promethazine hydrochloride (25 mg), or mixture (25 mg promethazine plus 10 mg d-amphetamine) group. Study II used 30 new subjects equally divided into control, dimenhydrinate (100 mg), and promethazine (50 mg) groups. Following practice, tests were conducted prior to, and 1, 2, and 4 h after drug ingestion. The depressant drugs had little effect on static tracking, but impaired dynamic tracking performance and reduced ability to maintain visual fixation on a localizer/glide slope instrument due to increased ocular nystagmus. The mixture of promethazine plus d-amphetamine produced none of these deleterious effects.
D000337:Aerospace Medicine; D000339:Affect / Q000187:drug effects; D001143:Arousal / Q000187:drug effects; D003913:Dextroamphetamine / Q000009:adverse effects* / Q000627:therapeutic use; D004111:Dimenhydrinate / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D009041:Motion Sickness / Q000188:drug therapy*; D009760:Nystagmus, Physiologic / Q000187:drug effects; D009949:Orientation / Q000187:drug effects; D011398:Promethazine / Q000009:adverse effects* / Q000627:therapeutic use; D011597:Psychomotor Performance / Q000187:drug effects*
D011398:Promethazine; D004111:Dimenhydrinate; D003913:Dextroamphetamine